Showing results (1931-1940 of 12,124) with videos related to
Sort By:
Pageof 1,213
Neuropharmacology|February 1, 1990
Increase in the isolation-induced social behavioural deficit by agonists at 5-HT1A receptorsH Francès, F Khidichian, C MonierNeuropharmacology|February 1, 1990
Binding of umespirone to the sigma receptor: evidence for multiple affinity statesY Itzhak, M Ruhland, H KrählingNeuropharmacology|February 1, 1990
Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997A Hirose, M Sasa, A Akaike, et al.Neuropharmacology|August 26, 2009
A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementiaRahul Agrawal, Ethika Tyagi, Rakesh Shukla, et al.Neuropharmacology|August 26, 2009
Evaluation of the effects of propylisopropylacetic acid (PIA) on neuronal growth cone morphologyJakob A Shimshoni, Emma C Dalton, Peter Watson, et al.Neuropharmacology|July 25, 2009
Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampusJason M Uslaner, Sophie Parmentier-Batteur, Rosemarie B Flick, et al.Neuropharmacology|July 25, 2009
Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminalsMassimo Grilli, Elisa Neri, Stefania Zappettini, et al.Neuropharmacology|July 25, 2009
The JNK pathway amplifies and drives subcellular changes in tau phosphorylationJ Vogel, V S Anand, B Ludwig, et al.Neuropharmacology|July 28, 2009
Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in miceAygul Balcioglu, Jia-Qian Ren, Deirdre McCarthy, et al.Neuropharmacology|July 18, 2009
Opiate-induced hypernociception and chemokine receptorsFletcher White, Natalie WilsonPageof 1,213